Started by Prosecutor Ray Grogan, the program allows low-level felony drug offenders the opportunity for a second chance at life through treatment and counseling.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.

For 25 years, 45-year-old Tony Serio was in active addiction. Today, he's successful and has been in recovery for eight years ...

Kennedy wants to create "wellness drug rehabilitation farms." But the U.S. tried it before, and it didn't work.

I have been seeking recovery from alcohol, heroin and pharmaceutical opioid use disorders since late 2013. The treatment system is fraught with barriers, especially so if you’re ...